These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28735345)

  • 21. Postoperative adjuvant OK-432 sclerotherapy for treatment of cervicofacial lymphatic malformations: an outcomes comparison.
    Kim SY; Lee S; Seo JM; Lim SY
    Int J Pediatr Otorhinolaryngol; 2015 Apr; 79(4):570-5. PubMed ID: 25698461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck.
    Sung MW; Lee DW; Kim DY; Lee SJ; Hwang CH; Park SW; Kim KH
    Laryngoscope; 2001 Aug; 111(8):1430-3. PubMed ID: 11568580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time MRI-guided percutaneous sclerotherapy of low-flow head and neck lymphatic malformations in the pediatric population - a stepwise approach.
    Partovi S; Vidal L; Lu Z; Nakamoto DA; Buethe J; Clampitt M; Coffey M; Patel IJ
    Pediatr Radiol; 2017 May; 47(6):755-760. PubMed ID: 28213627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy.
    Peters DA; Courtemanche DJ; Heran MKS; Ludemann JP; Prendiville JS
    Plast Reconstr Surg; 2006 Nov; 118(6):1441-1446. PubMed ID: 17051116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous sclerotherapy of lymphatic malformations with doxycycline.
    Burrows PE; Mitri RK; Alomari A; Padua HM; Lord DJ; Sylvia MB; Fishman SJ; Mulliken JB
    Lymphat Res Biol; 2008; 6(3-4):209-16. PubMed ID: 19093794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OK432 versus doxycycline for treatment of macrocystic lymphatic malformations.
    Motz KM; Nickley KB; Bedwell JR; Yadav B; Guzzetta PC; Oh AK; Bauman NM
    Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):81-8. PubMed ID: 24574462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Doxycycline sclerotherapy in children with head and neck lymphatic malformations.
    Cheng J
    J Pediatr Surg; 2015 Dec; 50(12):2143-6. PubMed ID: 26421368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations.
    Caton MT; Baker A; Smith ER; Perez E; Hemphill K; Cooke DL; Dowd CF
    J Neurointerv Surg; 2023 Sep; 15(9):931. PubMed ID: 35977819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous Treatment of Lymphatic Malformations.
    Acord M; Srinivasan AS; Cahill AM
    Tech Vasc Interv Radiol; 2016 Dec; 19(4):305-311. PubMed ID: 27993327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
    Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
    Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions.
    Bai Y; Jia J; Huang XX; Alsharif MJ; Zhao JH; Zhao YF
    J Oral Maxillofac Surg; 2009 Feb; 67(2):251-6. PubMed ID: 19138596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CYSTIC LYMPHATIC MALFORMATIONS IN CHILDREN: CLINICAL SIGNS AND CHOICE OF THE TREATMENT TACTIC].
    Benzar IM
    Klin Khir; 2016; (12):37-9. PubMed ID: 30272867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilizing immediate preoperative n-BCA in the resection of head and neck venous and lymphatic malformations.
    Puccia R; Staricha K; Carlberg VM; Moe D; Chun R
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110388. PubMed ID: 33152979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxycycline sclerotherapy as the primary treatment for head and neck lymphatic malformations.
    Cordes BM; Seidel FG; Sulek M; Giannoni CM; Friedman EM
    Otolaryngol Head Neck Surg; 2007 Dec; 137(6):962-4. PubMed ID: 18036431
    [No Abstract]   [Full Text] [Related]  

  • 36. Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.
    Ghaffarpour N; Petrini B; Svensson LA; Boman K; Wester T; Claesson G
    Acta Paediatr; 2015 Nov; 104(11):1169-73. PubMed ID: 26081020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Giant lymphangioma of the tongue.
    Hong JP; Lee MY; Kim EK; Seo DH
    J Craniofac Surg; 2009 Jan; 20(1):252-4. PubMed ID: 19165040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of OK-432 sclerotherapy in treatment of lymphatic malformations: long-term follow-up results.
    Weitz-Tuoretmaa A; Rautio R; Valkila J; Keski-Säntti H; Keski-Nisula L; Laranne J
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):385-90. PubMed ID: 23649509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerotherapy for intra-abdominal lymphatic malformations in children.
    Russell KW; Rollins MD; Feola GP; Arnold R; Barnhart DC; Scaife ER
    Eur J Pediatr Surg; 2014 Aug; 24(4):317-21. PubMed ID: 23846982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous treatment of lymphatic malformations.
    Shiels WE; Kang DR; Murakami JW; Hogan MJ; Wiet GJ
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):219-24. PubMed ID: 19643255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.